本页面由Tiger Trade Technology Pte. Ltd.提供服务

Prevail Therapeutics

23.00
0.0000
成交量:- -
成交额:- -
市值:1.58亿
市盈率:-9.96
高:23.00
开:23.00
低:23.00
收:23.00
52周最高:23.35
52周最低:9.02
股本:687.33万
流通股本:202.45万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.3102
每股收益(LYR):-2.2175
净资产收益率:-52.34%
总资产收益率:-29.11%
市净率:1.40
市盈率(LYR):-10.37

数据加载中...

2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/22

重要事件披露

8-K - Current report
2021/01/22

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/12/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/15

重要事件披露

8-K - Current report
2020/11/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/13

重要事件披露

8-K - Current report
2020/11/12

重要事件披露

8-K - Current report
2020/11/02

重要事件披露

8-K - Current report
2020/10/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/10

重要事件披露

8-K - Current report
2020/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

重要事件披露

8-K - Current report